| Fairmont Crossing Health And Rehabilitation | |
| 173 Brockman Park Drive, Amherst, Virginia 24521 | |
| (434) 946-2861 | |
| Name | Fairmont Crossing Health And Rehabilitation |
|---|---|
| Location | 173 Brockman Park Drive, Amherst, Virginia |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 120 |
| Occupancy Rate | 75.17% |
| Medicare ID (CCN) | 495363 |
| Legal Business Name | Centra Health, Inc |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1174297063 |
| Organization Name | AMHERST SNF OPERATIONS LLC |
| Doing Business As | FAIRMONT CROSSING HEALTH AND REHAB CENTER |
| Address | 173 Brockman Park Dr, Amherst, VA 24521 |
| Phone Number | 434-946-2850 |
News Archive
Defibtech, LLC is initiating a worldwide voluntary recall of certain DDU-100 series semi-automatic external defibrillators sold under the Lifeline AED and ReviveR AED brand names, including 65,885 AEDs distributed in the United States.
Aerogen,the innovative medical device and drug delivery company, has announced receipt of authorisation to market its Aeroneb Pro and Aeroneb Go products in China.
In today's news, a new survey shows that the percentage of Americans lacking health insurance coverage rose for the fourth straight year in 2011.
Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, announced today that Jessica Castle, M.D., an associate professor of medicine in the OHSU School of Medicine and OHSU Harold Schnitzer Diabetes Health Center in Portland, Oregon, is conducting a clinical trial with a dual-hormone artificial pancreas using Xeris' ready-to-use liquid glucagon to evaluate a new closed-loop algorithm.
A Brief Report appearing in the American Journal of Preventive Medicine looks at testing rates for Hepatitis C virus (HCV) two years after the United States Preventive Services Task Force recommended it for all baby boomers, and finds rates are still very low.
› Verified 8 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Defibtech, LLC is initiating a worldwide voluntary recall of certain DDU-100 series semi-automatic external defibrillators sold under the Lifeline AED and ReviveR AED brand names, including 65,885 AEDs distributed in the United States.
Aerogen,the innovative medical device and drug delivery company, has announced receipt of authorisation to market its Aeroneb Pro and Aeroneb Go products in China.
In today's news, a new survey shows that the percentage of Americans lacking health insurance coverage rose for the fourth straight year in 2011.
Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, announced today that Jessica Castle, M.D., an associate professor of medicine in the OHSU School of Medicine and OHSU Harold Schnitzer Diabetes Health Center in Portland, Oregon, is conducting a clinical trial with a dual-hormone artificial pancreas using Xeris' ready-to-use liquid glucagon to evaluate a new closed-loop algorithm.
A Brief Report appearing in the American Journal of Preventive Medicine looks at testing rates for Hepatitis C virus (HCV) two years after the United States Preventive Services Task Force recommended it for all baby boomers, and finds rates are still very low.
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $10888 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 26.28 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 5.79 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 34.68 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 7 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 3.6 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 7.55 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 95.05 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 21.22 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 65.14 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.56 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 35.34 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 3.25 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 7.37 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.26 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 66.52 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 80.63 | 82.93 |
News Archive
Defibtech, LLC is initiating a worldwide voluntary recall of certain DDU-100 series semi-automatic external defibrillators sold under the Lifeline AED and ReviveR AED brand names, including 65,885 AEDs distributed in the United States.
Aerogen,the innovative medical device and drug delivery company, has announced receipt of authorisation to market its Aeroneb Pro and Aeroneb Go products in China.
In today's news, a new survey shows that the percentage of Americans lacking health insurance coverage rose for the fourth straight year in 2011.
Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, announced today that Jessica Castle, M.D., an associate professor of medicine in the OHSU School of Medicine and OHSU Harold Schnitzer Diabetes Health Center in Portland, Oregon, is conducting a clinical trial with a dual-hormone artificial pancreas using Xeris' ready-to-use liquid glucagon to evaluate a new closed-loop algorithm.
A Brief Report appearing in the American Journal of Preventive Medicine looks at testing rates for Hepatitis C virus (HCV) two years after the United States Preventive Services Task Force recommended it for all baby boomers, and finds rates are still very low.
› Verified 8 days ago
Fairmont Crossing Health And Rehabilitation Location: 173 Brockman Park Drive, Amherst, Virginia 24521 Phone: (434) 946-2861 |